Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperglycemia × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 506 Neoplasms 466 Carcinoma, Non-Small-Cell Lung 397 Prostatic Neoplasms 279 Lung Neoplasms 246 Colorectal Neoplasms 243 Neoplasm Metastasis 218 Multiple Myeloma 195 Ovarian Neoplasms 176 Leukemia, Myeloid, Acute 171 Pancreatic Neoplasms 148 Melanoma 148 Recurrence 134 Squamous Cell Carcinoma of Head and Neck 132 Carcinoma, Hepatocellular 125 Brain Neoplasms 119 Stomach Neoplasms 117 Urinary Bladder Neoplasms 109 Glioblastoma 109 Triple Negative Breast Neoplasms 107 Carcinoma, Renal Cell 106 Lymphoma, Non-Hodgkin 102 Lymphoma 100 Head and Neck Neoplasms 98 Leukemia, Lymphocytic, Chronic, B-Cell 97 Hematologic Neoplasms 97 Endometrial Neoplasms 97 Precursor Cell Lymphoblastic Leukemia-Lymphoma 96 Lymphoma, Large B-Cell, Diffuse 88 Small Cell Lung Carcinoma 87

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05455619 2026-04-22

Amelia-1

SynDevRx, Inc.

Phase 1/2 Recruiting

Breast Neoplasms, Hyperglycemia, Hyperinsulinism, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡